Tag Archives: Multiple sclerosis

Back in June, the FDA extended its deadline for decision for Novartis’ multiple sclerosis prospect ofatumumab by three months. But it turns out that the agency was not needed for so long. U.S. regulators on Thursday removed the drug, which will go by the name Kesimpta, into relapsing forms of …

Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …